OKLOOklo Inc.

Next report: No date yet; none in the next 8 weeks
Last result: −$0.22Beat; vs −$0.29 expected on Nov 6
Stock move on it: +39.79%; two sessions around the report
Typical move: ±21.4%; average over 2 reports
Price: $24.44; −5.49% today · $6.41B cap

Past and upcoming reports


Nov 6, 2026	Sep 30, 2026	Time not given	−$0.29	Beat−$0.22	Beat+24.1%	+39.79%2d
Aug 10, 2026	Jun 30, 2026	Time not given	−$0.16	Missed−$0.28	Missed−75.0%	−2.91%2d

After the report

Nov 6, 2026 report

Oklo beat EPS estimates, but execution and capital needs remain the central investment debate

Oklo reported third-quarter EPS of -$0.22 versus -$0.26 estimated, while shares rose 13.93% to $26.83 on November 9. The print improved near-term sentiment, but the company still had no meaningful revenue-growth data, forward EPS growth was negative, and execution delays or additional capital could pressure the thesis.

Reported against expected

Reported EPS was -$0.22 for the quarter ended September 30, beating the -$0.26 estimate by $0.04, or 14.79%.

Guidance

No explicit numerical guidance was provided in the payload. management guidance tone is unknown.

How the stock reacted

Shares rose 13.93% to $26.83 on November 9, with volume of 19.9 million. the stock remained below its 50-day and 200-day moving averages.

What changed

EPS improved to -$0.22, beating the -$0.26 estimate by 14.79%.

What the price now assumes

The 13.93% share gain suggests relief, while 18.66% short interest preserves substantial volatility and skepticism.

What it means for the business

Keep a mixed bias. upgrade only if the next business update shows reactor progress without additional-capital or delay concerns.

The next one to three months, as we saw it then

Better case30%

A credible reactor-progress update could extend the relief rally and begin reversing the stock’s 65.65% six-month decline.

Base case45%

The EPS beat supports stabilization, but negative forward EPS growth and incomplete revenue data keep the shares range-bound and volatile.

Worse case25%

Further delays or capital requirements could undermine credibility and reverse the post-earnings rally.

If you hold it

Hold only while the next business update avoids new delays or financing needs. trim if either risk is confirmed.

If you are watching

Enter only after a reactor-progress update without additional-capital concerns. do not trade if execution status remains unspecified.

Scenario odds are a judgement, not measured.